Multivalve Involvement in Aortic Stenosis: Insights From a Narrative Review
Abstract
Many patients with severe aortic stenosis present with concomitant multivalvular heart disease. The management of this condition remains challenging and requires a multidisciplinary approach that integrates clinical, hemodynamic, and multimodality imaging data to define the most effective and durable treatment strategy. Although randomized evidence to guide treatment decisions in this setting is limited, percutaneous interventions to address additional valvular lesions are being increasingly adopted. This review provides an overview of the pathophysiology of valvular diseases commonly associated with severe aortic stenosis, highlighting their prognostic implications after surgical or transcatheter treatment and their impact on risk stratification and therapeutic management.
Article Details
Authors (8)
Quentin Battistolo
Quebec Heart & Lung Institute, Laval University, Quebec City, Canada (Q.B., M.A., P.Y.T., M.B., J.R.-C.).
Marisa Avvedimento
Quebec Heart & Lung Institute, Laval University, Quebec City, Canada (Q.B., M.A., P.Y.T., M.B., J.R.-C.).
Patrice Guerin
Nantes University, CHU Nantes, l’Institut du Thorax, France (Q.B., P.G.).
Pierre Yves Turgeon
Quebec Heart & Lung Institute, Laval University, Quebec City, Canada (Q.B., M.A., P.Y.T., M.B., J.R.-C.).
Mathieu Bernier
Quebec Heart & Lung Institute, Laval University, Quebec City, Canada (Q.B., M.A., P.Y.T., M.B., J.R.-C.).
Michael J. Mack
Baylor Scott and White the Heart Hospital Plano, Plano, TX
Patrick O’Gara
Harvard Medical School, Brigham and Women’s Hospital, Boston, MA (P.O.).
Josep Rodés-Cabau
Department of Cardiology, Quebec Heart & Lung Institute, Laval University, Quebec City, Canada (J.R.-C., M.C., E.S.).